Skip to content
OpenCapital
Get started

Utah Medical Products UTMD Earnings per common share - diluted (in dollars per share)

Earnings per common share - diluted (in dollars per share) at other companies

Avanos Medical logo
Avanos MedicalAVNS
$0.11-21.4%

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K—
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity0×—
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's earnings per common share - diluted (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's earnings per common share - diluted (in dollars per share)?
Utah Medical Products (UTMD) reported earnings per common share - diluted (in dollars per share) of $0.82 in Q1 2026.
How has Utah Medical Products's earnings per common share - diluted (in dollars per share) changed year-over-year?
Utah Medical Products's earnings per common share - diluted (in dollars per share) decreased by 10.9% year-over-year, from $0.92 to $0.82.
What is the long-term trend for Utah Medical Products's earnings per common share - diluted (in dollars per share)?
Over 4 years (2021 to 2025), Utah Medical Products's earnings per common share - diluted (in dollars per share) has grown at a -3.7% compound annual growth rate (CAGR), from $4.05 to $3.48.
What does earnings per common share - diluted (in dollars per share) mean?
This metric measures the earnings per share assuming all potentially dilutive securities, such as stock options or convertible bonds, are exercised or converted. It provides a more conservative view of per-share profitability by accounting for the potential increase in the total share count. Investors use this to assess the impact of potential dilution on shareholder value.